Concentration dependent mitochondrial effect of amiodarone - PubMed (original) (raw)
Concentration dependent mitochondrial effect of amiodarone
Gabor Varbiro et al. Biochem Pharmacol. 2003.
Abstract
Although, the antiarrhythmic effect of amiodarone is well characterized, its effect on post-ischemic heart and cardiomyocytes, as well as the mechanism of its toxicity on extracardiac tissues is still poorly understood. In this study, we analyzed energy metabolism in situ during ischemia-reperfusion in Langendorff-perfused heart model by measuring the high-energy phosphate metabolites using 31P NMR spectroscopy. The toxicity of amiodarone on cardiomyocytes and cell lines of extracardiac origin, as well as direct effect of the drug on mitochondrial functions in isolated mitochondria was also analyzed. Amiodarone, when was present at low concentrations and predominantly in membrane bound form, protected heart and mitochondrial energy metabolism from ischemia-reperfusion-induced damages in Langendorff-perfused heart model. Toxicity of the drug was significantly higher on hepatocytes and pancreatic cells than on cardiomyocytes. In isolated mitochondria, amiodarone did not induce reactive oxygen species formation, while it affected mitochondrial permeability transition in a concentration dependent way. Up to the concentration of 10 microM, the drug considerably inhibited Ca(2+)-induced permeability transition, while at higher concentrations it induced a cyclosporin A independent permeability transition of its own. At concentrations where it inhibited the Ca(2+)-induced permeability transition (IC(50)=3.9+/-0.8 microM), it did not affect, between 6 and 30 microM it uncoupled, while, at higher concentrations it inhibited the respiratory chain. Thus, the concentration dependent nature of amiodarone's effect on permeability transition together with the different sensitivities of the tissues toward amiodarone can be involved in the beneficial cardiac and the simultaneous toxic extracardiac effects of the drug.
Similar articles
- Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition.
Varbiro G, Toth A, Tapodi A, Bognar Z, Veres B, Sumegi B, Gallyas F Jr. Varbiro G, et al. J Pharmacol Exp Ther. 2003 Nov;307(2):615-25. doi: 10.1124/jpet.103.053553. Epub 2003 Sep 11. J Pharmacol Exp Ther. 2003. PMID: 12970391 - Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R, Berente Z, Osz E, Toth K, Literati-Nagy P, Sumegi B. Halmosi R, et al. Mol Pharmacol. 2001 Jun;59(6):1497-505. doi: 10.1124/mol.59.6.1497. Mol Pharmacol. 2001. PMID: 11353811 - Synthesis and evaluation of the permeability transition inhibitory characteristics of paramagnetic and diamagnetic amiodarone derivatives.
Kálai T, Várbiró G, Bognár Z, Pálfi A, Hantó K, Bognár B, Osz E, Sümegi B, Hideg K. Kálai T, et al. Bioorg Med Chem. 2005 Apr 1;13(7):2629-36. doi: 10.1016/j.bmc.2005.01.028. Bioorg Med Chem. 2005. PMID: 15755662 - Effects of amiodarone on cardiac function and mitochondrial oxidative phosphorylation during ischemia and reperfusion.
Moreau D, Clauw F, Martine L, Grynberg A, Rochette L, Demaison L. Moreau D, et al. Mol Cell Biochem. 1999 Apr;194(1-2):291-300. doi: 10.1023/a:1006935323491. Mol Cell Biochem. 1999. PMID: 10391152
Cited by
- Role of mitochondria in the pheromone- and amiodarone-induced programmed death of yeast.
Pozniakovsky AI, Knorre DA, Markova OV, Hyman AA, Skulachev VP, Severin FF. Pozniakovsky AI, et al. J Cell Biol. 2005 Jan 17;168(2):257-69. doi: 10.1083/jcb.200408145. J Cell Biol. 2005. PMID: 15657396 Free PMC article. - Potential therapeutic benefits of strategies directed to mitochondria.
Camara AK, Lesnefsky EJ, Stowe DF. Camara AK, et al. Antioxid Redox Signal. 2010 Aug 1;13(3):279-347. doi: 10.1089/ars.2009.2788. Antioxid Redox Signal. 2010. PMID: 20001744 Free PMC article. Review. - Comparison of Mitochondrial and Antineoplastic Effects of Amiodarone and Desethylamiodarone in MDA-MB-231 Cancer Line.
Ramadan FHJ, Koszegi B, Vantus VB, Fekete K, Kiss GN, Rizsanyi B, Bognar R, Gallyas F Jr, Bognar Z. Ramadan FHJ, et al. Int J Mol Sci. 2024 Sep 10;25(18):9781. doi: 10.3390/ijms25189781. Int J Mol Sci. 2024. PMID: 39337269 Free PMC article. - A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data.
Lu JT, Cai Y, Chen F, Jia WW, Hu ZY, Zhao YS. Lu JT, et al. Eur J Drug Metab Pharmacokinet. 2016 Dec;41(6):689-703. doi: 10.1007/s13318-015-0295-0. Eur J Drug Metab Pharmacokinet. 2016. PMID: 26254911 - Tumor necrosis factor-alpha potentiates the cytotoxicity of amiodarone in Hepa1c1c7 cells: roles of caspase activation and oxidative stress.
Lu J, Miyakawa K, Roth RA, Ganey PE. Lu J, et al. Toxicol Sci. 2013 Jan;131(1):164-78. doi: 10.1093/toxsci/kfs289. Epub 2012 Oct 5. Toxicol Sci. 2013. PMID: 23042730 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous